Cumberland Pharmaceuticals Inc. Cost of Revenue
Cumberland Pharmaceuticals Inc. (CPIX) reported Cost of Revenue of $1.93 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-05-08
- Cumberland Pharmaceuticals Inc. cost of goods and services sold for the quarter ending 2026-03-31 was $1.93M, a 35.64% increase year-over-year.
- Cumberland Pharmaceuticals Inc. cost of goods and services sold for the quarter ending 2025-12-31 was $2.24M, a 13.40% increase year-over-year.
- Cumberland Pharmaceuticals Inc. cost of goods and services sold for the quarter ending 2025-09-30 was $988.76K, a 25.26% decline year-over-year.
- Cumberland Pharmaceuticals Inc. cost of goods and services sold for the quarter ending 2025-06-30 was $2.01M, a 17.56% increase year-over-year.
- Cumberland Pharmaceuticals Inc. cost of goods and services sold for fiscal 2025 was $6.67M, a 1.23% increase from fiscal 2024.
- Cumberland Pharmaceuticals Inc. cost of goods and services sold for fiscal 2024 was $6.59M, a 8.56% increase from fiscal 2023.
- Cumberland Pharmaceuticals Inc. cost of goods and services sold for fiscal 2023 was $6.07M, a 33.47% decline from fiscal 2022.
- Cumberland Pharmaceuticals Inc. cost of goods and services sold for fiscal 2022 was $9.12M, a 3.49% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 3 month as first filed | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 6 month as first filed | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 9 month as first filed | Cost of Goods and Services Sold 12 month | Cost of Goods and Services Sold 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $1.93M 10-Q · filed 2026-05-08 | $4.18M derived: sum of 2 quarters · filed 2026-05-08 | $5.16M derived: sum of 3 quarters · filed 2026-05-08 | $7.18M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2025-12-31 | $2.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $3.23M derived: sum of 2 quarters · filed 2026-03-09 | $5.24M derived: sum of 3 quarters · filed 2026-03-09 | $6.67M 10-K · filed 2026-03-09 | ||||
| 2025-09-30 | $988.76K 10-Q · filed 2025-11-07 | $3.00M derived: sum of 2 quarters · filed 2025-11-07 | $4.43M 10-Q · filed 2025-11-07 | $6.40M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2025-06-30 | $2.01M 10-Q · filed 2025-08-08 | $3.44M 10-Q · filed 2025-08-08 | $5.41M derived: sum of 3 quarters · filed 2026-05-08 | $6.74M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2025-03-31 | $1.43M 10-Q · filed 2026-05-08 | $3.40M derived: sum of 2 quarters · filed 2026-05-08 | $4.73M derived: sum of 3 quarters · filed 2026-05-08 | $6.44M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | $1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $3.30M derived: sum of 2 quarters · filed 2026-03-09 | $5.01M derived: sum of 3 quarters · filed 2026-03-09 | $6.59M 10-K · filed 2026-03-09 | ||||
| 2024-09-30 | $1.32M 10-Q · filed 2025-11-07 | $3.03M derived: sum of 2 quarters · filed 2025-11-07 | $4.61M 10-Q · filed 2025-11-07 | $6.14M derived: sum of 4 quarters · filed 2025-11-07 | ||||
| 2024-06-30 | $1.71M 10-Q · filed 2025-08-08 | $3.29M 10-Q · filed 2025-08-08 | $4.82M derived: sum of 3 quarters · filed 2025-08-08 | $6.58M derived: sum of 4 quarters · filed 2025-08-08 | ||||
| 2024-03-31 | $1.58M 10-Q · filed 2025-05-09 | $3.11M derived: sum of 2 quarters · filed 2025-05-09 | $4.87M derived: sum of 3 quarters · filed 2025-05-09 | $6.39M derived: sum of 4 quarters · filed 2025-05-09 | ||||
| 2023-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $3.30M derived: sum of 2 quarters · filed 2025-03-07 | $4.82M derived: sum of 3 quarters · filed 2025-03-07 | $6.07M 10-K · filed 2025-03-07 | ||||
| 2023-09-30 | $1.77M 10-Q · filed 2024-11-08 | $3.29M derived: sum of 2 quarters · filed 2024-11-08 | $4.54M 10-Q · filed 2024-11-08 | $7.19M derived: sum of 4 quarters · filed 2024-11-08 | ||||
| 2023-06-30 | $1.52M 10-Q · filed 2024-08-09 | $2.77M 10-Q · filed 2024-08-09 | $5.42M derived: sum of 3 quarters · filed 2024-08-09 | $7.65M derived: sum of 4 quarters · filed 2024-08-09 | ||||
| 2023-03-31 | $1.25M 10-Q · filed 2024-05-10 | $3.90M derived: sum of 2 quarters · filed 2024-05-10 | $6.13M derived: sum of 3 quarters · filed 2024-05-10 | $8.16M derived: sum of 4 quarters · filed 2024-05-10 | ||||
| 2022-12-31 | $2.65M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $4.87M derived: sum of 2 quarters · filed 2024-03-13 | $6.91M derived: sum of 3 quarters · filed 2024-03-13 | $9.12M 10-K · filed 2024-03-13 | ||||
| 2022-09-30 | $2.22M 10-Q · filed 2023-11-13 | $4.26M derived: sum of 2 quarters · filed 2023-11-13 | $6.47M 10-Q · filed 2023-11-13 | $9.79M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $2.03M 10-Q · filed 2023-08-11 | $4.24M 10-Q · filed 2023-08-11 | $7.57M derived: sum of 3 quarters · filed 2023-08-11 | $8.90M derived: sum of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | $2.21M 10-Q · filed 2023-05-12 | $5.54M derived: sum of 2 quarters · filed 2023-05-12 | $6.87M derived: sum of 3 quarters · filed 2023-05-12 | $8.61M derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | $3.33M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $4.65M derived: sum of 2 quarters · filed 2023-03-13 | $6.39M derived: sum of 3 quarters · filed 2023-03-13 | $8.81M 10-K · filed 2023-03-13 | ||||
| 2021-09-30 | $1.33M 10-Q · filed 2022-11-14 | $3.07M derived: sum of 2 quarters · filed 2022-11-14 | $5.49M 10-Q · filed 2022-11-14 | $7.75M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $1.74M 10-Q · filed 2022-08-12 | $4.16M 10-Q · filed 2022-08-12 | $6.42M derived: sum of 3 quarters · filed 2022-08-12 | $8.57M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | $2.42M 10-Q · filed 2022-05-13 | $4.68M derived: sum of 2 quarters · filed 2022-05-13 | $6.83M derived: sum of 3 quarters · filed 2022-05-13 | $9.44M derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | $2.27M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $4.41M derived: sum of 2 quarters · filed 2022-03-11 | $7.02M derived: sum of 3 quarters · filed 2022-03-11 | $8.65M 10-K · filed 2022-03-11 | ||||
| 2020-09-30 | $2.14M 10-Q · filed 2021-11-12 | $4.75M derived: sum of 2 quarters · filed 2021-11-12 | $6.39M 10-Q · filed 2021-11-12 | $8.78M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2020-06-30 | $2.61M 10-Q · filed 2021-08-13 | $4.24M 10-Q · filed 2021-08-13 | $6.63M derived: sum of 3 quarters · filed 2022-03-11 | $8.21M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2020-03-31 | $1.63M 10-Q · filed 2021-05-14 | $4.02M derived: sum of 2 quarters · filed 2022-03-11 | $5.60M derived: sum of 3 quarters · filed 2022-03-11 | $7.40M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2019-12-31 | $2.39M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $3.97M derived: sum of 2 quarters · filed 2022-03-11 | $5.76M derived: sum of 3 quarters · filed 2022-03-11 | $7.42M 10-K · filed 2022-03-11 | $8.75M 10-K · filed 2020-03-20 | |||
| 2019-09-30 | $1.58M 10-Q · filed 2020-11-13 | $1.92M 10-Q · filed 2019-11-13 | $3.37M derived: sum of 2 quarters · filed 2020-11-13 | $5.03M 10-Q · filed 2020-11-13 | $5.93M 10-Q · filed 2019-11-13 | $6.54M derived: sum of 4 quarters · filed 2021-03-12 | ||
| 2019-06-30 | $1.79M 10-Q · filed 2020-08-14 | $2.01M 10-Q · filed 2019-08-14 | $3.45M 10-Q · filed 2020-08-14 | $4.01M 10-Q · filed 2019-08-14 | $4.96M derived: sum of 3 quarters · filed 2021-03-12 | $6.42M derived: sum of 4 quarters · filed 2021-03-12 | ||
| 2019-03-31 | $1.66M 10-Q · filed 2020-05-22 | $2.00M 10-Q · filed 2019-05-15 | $3.16M derived: sum of 2 quarters · filed 2021-03-12 | $4.62M derived: sum of 3 quarters · filed 2021-03-12 | $6.15M derived: sum of 4 quarters · filed 2021-03-12 | |||
| 2018-12-31 | $1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $2.97M derived: sum of 2 quarters · filed 2021-03-12 | $4.49M derived: sum of 3 quarters · filed 2021-03-12 | $6.02M 10-K · filed 2021-03-12 | $7.38M 10-K · filed 2019-03-12 | |||
| 2018-09-30 | $1.46M 10-Q · filed 2019-11-13 | $2.98M derived: sum of 2 quarters · filed 2019-11-13 | $4.51M 10-Q · filed 2019-11-13 | $4.71M derived: sum of 4 quarters · filed 2020-12-10 | ||||
| 2018-06-30 | $1.52M 10-Q · filed 2019-08-14 | $3.05M 10-Q · filed 2019-08-14 | $3.25M derived: sum of 3 quarters · filed 2020-12-10 | $5.42M derived: sum of 4 quarters · filed 2020-12-10 | ||||
| 2018-03-31 | $1.53M 10-Q · filed 2019-05-15 | $1.73M derived: sum of 2 quarters · filed 2020-12-10 | $3.90M derived: sum of 3 quarters · filed 2020-12-10 | |||||
| 2017-12-31 | $201.23K derived: 8-K 12 month − 10-Q 9 month · filed 2020-12-10 | $2.37M derived: sum of 2 quarters · filed 2020-12-10 | $5.42M 8-K · filed 2020-12-10 | $7.37M 10-K · filed 2019-03-12 | ||||
| 2017-09-30 | $2.17M 10-Q · filed 2018-11-14 | $5.22M 10-Q · filed 2018-11-14 | ||||||
| 2016-12-31 | $5.96M 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |